PT  - JOURNAL ARTICLE
AU  - Sinha, Koushiki
AU  - Chakraborty, Sanchari
AU  - Bardhan, Arohit
AU  - Saha, Riju
AU  - Chakraborty, Srijan
AU  - Biswas, Surama
TI  - A New Differential Gene Expression Based Simulated Annealing for Solving Gene Selection Problem: A Case Study on Eosinophilic Esophagus and Few Other Gastro-Intestinal Diseases
AID  - 10.1101/2024.05.03.24306738
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.05.03.24306738
4099  - http://medrxiv.org/content/early/2024/05/05/2024.05.03.24306738.short
4100  - http://medrxiv.org/content/early/2024/05/05/2024.05.03.24306738.full
AB  - Identification of the set of genes collectively causes a disease is an important problem, called gene selection problem. This study introduces two distinct approaches for gene selection in the context of biological diseases: the Ranked Variance (RV) method and Differential Gene Expression Based Simulated Annealing (DGESA). The RV method prioritizes genes based on their variance, offering an initial perspective on potential biomarkers. DGESA, on the other hand, employs simulated annealing, integrating differential gene expression data to refine gene selection further. Through a case study focused on Eosinophilic Esophagus (EoE) and other gastro-intestinal diseases, we compare and contrast the outcomes of both methods. Notably, we identify 10 common genes between RV and DGESA in EoE, highlighting their complementary nature. Validation analyses reveal that 13 out of 40 final genes identified by DGESA for EoE are corroborated by existing literature, indicating their biological relevance. Similarly, in Ulcerative Colitis (UC) and Crohn’s Disease (CD), 8 and 7 genes, respectively, out of the final 40 genes identified exhibit confirmation in the literature. These findings underscore the efficacy of both RV and DGESA in elucidating molecular signatures associated with gastro-intestinal diseases, contributing to our understanding of their pathogenesis and potential therapeutic targets.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors